India to Saudi Arabia: Posaconazole Export Trade Route

The India to Saudi Arabia Posaconazole corridor is one of India's established pharmaceutical export routes, with 13 shipments documented worth a combined $1.2M USD. The route is dominated by AET LABORATORIES PRIVATE LIMITED, which alone accounts for roughly 94% of all export value, reflecting the consolidated nature of India's posaconazole manufacturing sector.

Across 5 active suppliers, the average shipment value stands at $88.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with posaconazole's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 15.4%, placing it at rank #8 among India's top posaconazole export destinations globally.

On the import side, key buyers of Indian posaconazole in Saudi Arabia include M/S.PHARMA PHARMACEUTICAL, M/S PHARMA PHARMACEUTICAL INDUSTRIE, ST PHARMA and 3 others. M/S.PHARMA PHARMACEUTICAL is the single largest importer with 5 shipments valued at $822.0K USD.

India's posaconazole exports to Saudi Arabia are driven primarily by a handful of large-scale manufacturers. AET LABORATORIES PRIVATE LIMITED with 6 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Saudi Arabia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — AET LABORATORIES PRIVATE LIMITED, CSC PHARMACEUTICALS INTERNATIONAL, PROGNOGEN GLOBAL HEALTHCARE PRIVATE LIMITED — together account for 99% of total trade value on this route. The average shipment value of $88.9K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as posaconazole 100mg gr tablets,(batch.no.cl212-1) and posaconazole 100mg gastro-resistant tablets, suggesting that buyers in Saudi Arabia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, M/S.PHARMA PHARMACEUTICAL is the largest importer with 5 shipments worth $822.0K USD — representing 71% of all posaconazole imports from India on this route. A total of 6 buyers are active on this corridor.